Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedTech SolutionsWAR:MDT +6.04%29 PB Ratio is 10.19 as of Jul. 16, 2026, which is 14% below its 10-year median of 11.87. GuruFocus rates WAR:MDT with a GF Score™ of 29/100 and a GF Value™ of zł0.04 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 1,076 Retail - Cyclical companies, MedTech Solutions ranks worse than 93.4% on this metric.
The historical rank and industry rank for MedTech Solutions's PB Ratio or its related term are showing as below:
WAR:MDT'
s PB Ratio Range Over the Past 10 Years
Min: 1.32 Med: 11.87 Max: 1401.65
Current: 10.2
During the past 12 years, MedTech Solutions's highest PB Ratio was 1401.65. The lowest was 1.32. And the median was 11.87.
WAR:MDT's PB Ratio is ranked worse than 93.4% of 1076
companies
in the Retail - Cyclical industry
Industry Median: 1.47
vs WAR:MDT: 10.20
During the past 3 years, the average Book Value Per Share Growth Rate was 230.20% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of MedTech Solutions was 230.20% per year. The lowest was -94.30% per year. And the median was 67.95% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
MedTech Solutions PB Ratio Related Terms
MedTech Solutions PB Ratio Historical Data
* Premium members only.
The historical data trend for MedTech Solutions's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Internet Retail subindustry, MedTech Solutions's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedTech Solutions PB Ratio vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, MedTech Solutions's PB Ratio distribution charts can be found below:
* The bar in red indicates where MedTech Solutions's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
MedTech Solutions (WAR:MDT) has a PB Ratio of 10.19 as of Jul. 16, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MedTech Solutions and its competitors. This is 14% below median its historical median of 11.87. Over the past decade, MedTech Solutions' PB Ratio has ranged from 1.32 to 1,401.65. According to the industry distribution chart, MedTech Solutions ranks #1005 out of 1076 companies in the Retail - Cyclical industry, placing it in the top 93.4%.
Is MedTech Solutions' PB Ratio too high?
MedTech Solutions' current PB Ratio of 10.19 is 14% below median its 10-year median of 11.87. Over the past 10 years, this metric has ranged from a low of 1.32 to a high of 1,401.65. The Retail - Cyclical industry median PB Ratio is 1.47. MedTech Solutions' value of 10.19 is 593.2% above this industry median. Based on the distribution chart, MedTech Solutions ranks #1005 out of 1076 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, MedTech Solutions has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MedTech Solutions' PB Ratio compare to AMZN and BABA?
According to the Retail - Cyclical industry distribution chart, MedTech Solutions ranks #1005 out of 1076 companies for PB Ratio. This places MedTech Solutions in the lower half of its industry. The industry median PB Ratio is 1.47. MedTech Solutions' value of 10.19 is 593.2% above this benchmark. Historically, MedTech Solutions' own PB Ratio has ranged from 1.32 to 1,401.65 over the past decade. While the company's 10-year median is 11.87 vs. the industry median of 1.47, MedTech Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Retail - Cyclical company?
The median PB Ratio among Retail - Cyclical companies is 1.47, based on 1,076 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedTech Solutions's current PB Ratio of 10.19 is 593.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MedTech Solutions and its competitors. For the Retail - Cyclical industry, the median PB Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedTech Solutions's current PB Ratio is 10.19, which is 14% below median its own 10-year median of 11.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedTech Solutions stock overvalued right now?
Based on GuruFocus' analysis, MedTech Solutions (WAR:MDT) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.04, compared to a current price of zł0.32 — trading 690% above its estimated fair value. The current PB Ratio is 10.19, which is 14% below median its 10-year median of 11.87 and 593.2% above the Retail - Cyclical industry median of 1.47. MedTech Solutions' overall GF Score™ is 29/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For MedTech Solutions (WAR:MDT), the current PB Ratio is 10.19 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedTech Solutions (WAR:MDT) Overvalued in 2026?
Based on GuruFocus' analysis, MedTech Solutions stock appears to be overvalued.
The current stock price of zł0.32 is trading 690% above its estimated GF Value™ of zł0.04.
GuruFocus considers MedTech Solutions to be Significantly Overvalued.
Key valuation signals for WAR:MDT:
PB Ratio: 10.19 (14% below median its 10-year median of 11.87)
GF Value™: zł0.04 vs. price of zł0.32 (690% above fair value)
Industry Position: 593.2% above the Retail - Cyclical median (#1005 of 1076)
No single metric tells the full story. See the WAR:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedTech Solutions SA formerly E-shopping Group SA main activity is based on conducting business through its own e-shops that operate in the dropshipping sales model.
29GF Score
Get the complete analysis for WAR:MDT
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MDT has been successfully added to your 
